Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation

Circulation
B BrennerV J Marder

Abstract

Plasma cross-linked fibrin-degradation products were analyzed using a D-dimer (DD) immunoassay in patients with deep vein thrombosis (DVT) or acute myocardial infarction (MI) treated with fibrinolytic therapy, and the results were correlated with clot lysis documented angiographically. In 13 patients with DVT, the mean DD concentration increased 10-fold (1,074 +/- 252 to 10,333 +/- 1,004 ng/ml) during therapy, but neither the peak level nor the DD concentration integrated over the course of therapy correlated with clot lysis. Since plasma DD can derive from degradation of soluble plasma fibrin as well as from thrombi, the contribution of the former was estimated by in vitro incubation of the pretreatment plasma with plasminogen activator. Subtraction of this value from the measured posttreatment DD concentration provided a "corrected" level that represented DD originating from lysis of thrombi. This modification resulted in improved correlation of DD levels with clot lysis. The mean corrected peak DD was higher in patients with successful thrombolysis (8,780 +/- 1,352 ng/ml) compared with patients without lysis (3,075 +/- 589 ng/ml, p less than 0.001). There was a moderate correlation between the volume of clot lysed and the co...Continue Reading

References

Jul 1, 1976·Cardiovascular Research·P J GaffneyM F Scully
May 1, 1988·American Journal of Clinical Pathology·D V Devine, C S Greenberg
Jan 1, 1987·American Journal of Clinical Pathology·C S GreenbergK M McCrae
Jan 25, 1973·Biochimica Et Biophysica Acta·P J Gaffney, M Brasher

❮ Previous
Next ❯

Citations

Jan 1, 1990·European Journal of Nuclear Medicine·K Z WalkerG R Boniface
Jan 5, 2002·The New England Journal of Medicine·Wayne L ChandlerPhillip I Tarr
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·H KeJ Friedman
Nov 15, 2008·Blood·Soheir S AdamCharles S Greenberg
Dec 4, 1992·Annals of the New York Academy of Sciences·C W Francis, A Kornberg
Oct 1, 1991·American Heart Journal·D R HirschS Z Goldhaber
Dec 10, 2019·Perfusion·Carlo BanfiRaphaël Giraud
Jul 1, 1991·DICP : the Annals of Pharmacotherapy·P Gal, J L Ransom

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.